Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 676 (LINC00676) is a long non-coding RNA (lncRNA) gene located on chromosome 13q34, encoded by the loci 13:109728282–109730319 (GRCh38 coordinates)[1][3][5][7][8][9]. Unlike protein-coding genes, lncRNAs function primarily as RNA molecules and do not encode proteins. The precise function of LINC00676 remains uncharacterized in the curated biomedical literature and major gene databases cited here; it has not been definitively established as a therapeutic target, receptor, transporter, enzyme, or key biomarker for any disease[1][3][5][7][8][9]. Most available references list this gene in the context of genomic annotation or as a candidate lncRNA, but provide no direct links to targetable mechanisms, known interacting drugs, or major disease roles. Therefore, it is not currently classified as a therapeutic target or major disease biomarker in clinical or research guidelines.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 676 (LINC00676).